Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Osteoclast differentiation	13/127	1.775093946360688E-5	0.00546728935479092	0	0	4.102693576128635	44.87966089877773	SPI1;SYK;NCF4;LILRA1;LILRA2;LILRA5;FOSL1;TYROBP;FCGR3B;AKT2;BTK;FCGR2B;MAP2K6
Hematopoietic cell lineage	9/97	7.132511399317303E-4	0.10984067554948647	0	0	3.718777761708985	26.94506238326173	IL11;ITGAM;CR1;FLT3;ITGA2;CD1D;CD1C;CD33;HLA-DPA1
Platelet activation	9/124	0.00393271576267775	0.40375881830158233	0	0	2.909043894240093	16.11152159866557	SYK;AKT2;ITGA2;P2RX1;TBXAS1;BTK;PRKACA;RASGRP2;MYL12A
Tuberculosis	11/179	0.00542075152795714	0.4173978676526998	0	0	2.4630266118829836	12.85089261502421	ITGAM;FCGR3B;CR1;SYK;AKT2;ITGB2;CARD9;TCIRG1;FCGR2B;ATP6V0A1;HLA-DPA1
Fc gamma R-mediated phagocytosis	7/91	0.007712307108642946	0.4750781178924055	0	0	3.083089255433945	14.999037768731213	GSN;SYK;ARPC1B;AKT2;INPPL1;WAS;FCGR2B
Leishmaniasis	6/74	0.010379500416805765	0.5328143547293626	0	0	3.2497427287006446	14.844573033000467	ITGAM;FCGR3B;CR1;ITGB2;NCF4;HLA-DPA1
Phagosome	9/152	0.014193490684288426	0.6245135901086908	0	0	2.3731673874063914	10.097760362275961	ITGAM;FCGR3B;ITGA2;NCF4;ITGB2;TCIRG1;FCGR2B;ATP6V0A1;HLA-DPA1
Fc epsilon RI signaling pathway	5/68	0.027329937014096112	1.0	0	0	2.947070611811859	10.608783990593563	SYK;AKT2;ALOX5;BTK;MAP2K6
Staphylococcus aureus infection	5/68	0.027329937014096112	0.9352911778157336	0	0	2.947070611811859	10.608783990593563	ITGAM;FCGR3B;ITGB2;FCGR2B;HLA-DPA1
B cell receptor signaling pathway	5/71	0.03215413610928344	0.99034739216593	0	0	2.8225465014536115	9.701696876024565	SYK;AKT2;INPPL1;BTK;FCGR2B
Malaria	4/49	0.033556365135316776	0.9395782237888697	0	0	3.2718498220931655	11.10638816468971	CR1;LRP1;GYPC;ITGB2
Glucagon signaling pathway	6/103	0.04422228412323768	1.0	0	0	2.3347666206198805	7.281031463929472	LDHC;AKT2;PYGL;PRKACA;FBP1;CREB5
Legionellosis	4/55	0.04815323704518734	1.0	0	0	2.9149207505920933	8.842024163658012	PYCARD;ITGAM;CR1;ITGB2
Human T-cell leukemia virus 1 infection	10/219	0.04871446534551358	1.0	0	0	1.8301443068785972	5.530292115401894	FOSL1;SPI1;CHEK2;AKT2;ITGB2;PRKACA;IL2;HLA-DPA1;CREB5;SLC25A6
Dilated cardiomyopathy (DCM)	5/91	0.077374648832407	1.0	0	0	2.202206611024246	5.635658319942324	SGCA;ITGA2;CACNA2D3;CACNA2D4;PRKACA
Rheumatoid arthritis	5/91	0.077374648832407	1.0	0	0	2.202206611024246	5.635658319942324	IL11;ITGB2;TCIRG1;HLA-DPA1;ATP6V0A1
Acute myeloid leukemia	4/66	0.08258943168134009	1.0	0	0	2.4291006254934113	6.057869806005826	SPI1;ITGAM;FLT3;AKT2
Autophagy	6/128	0.10141247244246993	1.0	0	0	1.8787575150300602	4.299647782436133	ATG16L2;AKT2;ATG10;PRKACA;ZFYVE1;CAMKK2
Chemokine signaling pathway	8/190	0.1040276183991464	1.0	0	0	1.6875856977112118	3.8191732577841697	CX3CR1;GSK3A;AKT2;CXCR2;WAS;ARRB1;PRKACA;RASGRP2
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	4/72	0.10531919102099033	1.0	0	0	2.22667557336896	5.011711479706742	SGCA;ITGA2;CACNA2D3;CACNA2D4
Thyroid hormone synthesis	4/74	0.11346553890858065	1.0	0	0	2.1664951524670966	4.714848313088854	PRKACA;ASGR1;ASGR2;CREB5
C-type lectin receptor signaling pathway	5/104	0.11879563848371137	1.0	0	0	1.9269307846462156	4.105038125920316	PYCARD;SYK;AKT2;CARD9;IL2
Ovarian steroidogenesis	3/49	0.12303208395108468	1.0	0	0	2.4538873665698744	5.141655014092984	ALOX5;CYP1A1;PRKACA
Cholesterol metabolism	3/50	0.128601317189854	1.0	0	0	2.4048096192384767	4.932356452177673	LRP1;OSBPL5;SORT1
Vibrio cholerae infection	3/50	0.128601317189854	1.0	0	0	2.4048096192384767	4.932356452177673	TCIRG1;PRKACA;ATP6V0A1
Insulin resistance	5/108	0.13328679155478806	1.0	0	0	1.8555629778074667	3.7394272708716367	AKT2;RPS6KA1;PYGL;SLC27A3;CREB5
Tight junction	7/170	0.13383636760233403	1.0	0	0	1.6503595426146411	3.3190997377485445	MARVELD2;WAS;ARHGEF18;CD1D;PRKACA;CD1C;MYL12A
Complement and coagulation cascades	4/79	0.1349843201913791	1.0	0	0	2.029375206108419	4.0640199975034355	ITGAM;CR1;ITGB2;A2M
Biosynthesis of unsaturated fatty acids	2/27	0.1451644549749239	1.0	0	0	2.9689007644919467	5.72964597939032	FADS2;FADS1
Collecting duct acid secretion	2/27	0.1451644549749239	1.0	0	0	2.9689007644919467	5.72964597939032	TCIRG1;ATP6V0A1
Endocytosis	9/244	0.15810954957803677	1.0	0	0	1.4783665692039818	2.7267985495703764	VPS29;CYTH4;CAPZB;IQSEC1;ARPC1B;CXCR2;WAS;ARRB1;EPN1
Hypertrophic cardiomyopathy (HCM)	4/85	0.16278432837254328	1.0	0	0	1.8861251915595898	3.423937933495602	SGCA;ITGA2;CACNA2D3;CACNA2D4
Regulation of actin cytoskeleton	8/214	0.16756152952414213	1.0	0	0	1.498323750304347	2.676612521832238	DIAPH2;GSN;ITGAM;ARPC1B;ITGA2;ITGB2;WAS;MYL12A
Nicotinate and nicotinamide metabolism	2/30	0.17159496050911424	1.0	0	0	2.6720106880427523	4.709735364120289	BST1;NADSYN1
Pentose phosphate pathway	2/30	0.17159496050911424	1.0	0	0	2.6720106880427523	4.709735364120289	TKT;FBP1
Viral myocarditis	3/59	0.1822794030321869	1.0	0	0	2.03797425359193	3.469069503609821	SGCA;ITGB2;HLA-DPA1
Lysosome	5/123	0.19388141088056493	1.0	0	0	1.6292748097821659	2.6728393224659404	SORT1;ARSG;TCIRG1;CTSF;ATP6V0A1
MAPK signaling pathway	10/295	0.2041215989189862	1.0	0	0	1.3586495023946197	2.158947575947367	FLT3;AKT2;RPS6KA1;CACNA2D3;ARRB1;CACNA2D4;PRKACA;RASGRP2;RASGRP4;MAP2K6
Hippo signaling pathway	6/160	0.21095942763964337	1.0	0	0	1.503006012024048	2.3388117986925567	RASSF1;FRMD6;FZD2;RASSF4;ITGB2;NKD1
Amoebiasis	4/96	0.21833576050157452	1.0	0	0	1.67000668002672	2.5412845946487663	ITGAM;ITGB2;CD1D;PRKACA
Natural killer cell mediated cytotoxicity	5/131	0.22952919490766185	1.0	0	0	1.5297771114748582	2.2514112907425994	TYROBP;FCGR3B;SYK;ITGB2;HCST
Epithelial cell signaling in Helicobacter pylori infection	3/68	0.24069522750495437	1.0	0	0	1.7682423670871155	2.518372796101562	CXCR2;TCIRG1;ATP6V0A1
Taurine and hypotaurine metabolism	1/11	0.24270438526211566	1.0	0	0	3.6436509382401168	5.159085799816664	GGT7
Allograft rejection	2/38	0.2448659994548925	1.0	0	0	2.1094821221390148	2.968134498606979	IL2;HLA-DPA1
Longevity regulating pathway	4/102	0.25053402640782724	1.0	0	0	1.5717709929663248	2.1755833765074195	AKT2;PRKACA;CREB5;CAMKK2
Insulin signaling pathway	5/137	0.25741152678544077	1.0	0	0	1.462779573746032	1.9851077384207214	AKT2;INPPL1;PYGL;PRKACA;FBP1
Ferroptosis	2/40	0.26346556444202246	1.0	0	0	2.0040080160320644	2.6730112320046	PCBP1;GCLM
Bladder cancer	2/41	0.27276984512891855	1.0	0	0	1.9551297717385991	2.5399616745811175	RASSF1;UPK3A
Graft-versus-host disease	2/41	0.27276984512891855	1.0	0	0	1.9551297717385991	2.5399616745811175	IL2;HLA-DPA1
Inositol phosphate metabolism	3/74	0.28117407837650027	1.0	0	0	1.6248713643503223	2.0616064108569248	FIG4;IMPA2;INPPL1
Type I diabetes mellitus	2/43	0.29135825394517834	1.0	0	0	1.864193503285641	2.2989265149749634	IL2;HLA-DPA1
Pertussis	3/76	0.29481431932337215	1.0	0	0	1.582111591604261	1.9324062021461406	PYCARD;ITGAM;ITGB2
Adrenergic signaling in cardiomyocytes	5/145	0.29572740502498984	1.0	0	0	1.3820744938152165	1.6838050970123954	AKT2;CACNA2D3;CACNA2D4;PRKACA;CREB5
Vasopressin-regulated water reabsorption	2/44	0.3006315833357493	1.0	0	0	1.8218254691200584	2.1895969020440007	PRKACA;CREB5
Leukocyte transendothelial migration	4/112	0.30607547762490034	1.0	0	0	1.43143429716576	1.694708772602576	ITGAM;NCF4;ITGB2;MYL12A
Cardiac muscle contraction	3/78	0.30849446949072695	1.0	0	0	1.5415446277169724	1.812935660388309	CACNA2D3;CACNA2D4;COX6C
Toxoplasmosis	4/113	0.311713181627131	1.0	0	0	1.4187667370138506	1.6538163812725102	AKT2;ALOX5;MAP2K6;HLA-DPA1
Thiamine metabolism	1/15	0.31554444134617654	1.0	0	0	2.6720106880427523	3.0820460838194843	TPK1
Cysteine and methionine metabolism	2/47	0.3283089077825412	1.0	0	0	1.705538737048565	1.8996295941430157	LDHC;GCLM
Hedgehog signaling pathway	2/47	0.3283089077825412	1.0	0	0	1.705538737048565	1.8996295941430157	ARRB1;PRKACA
Oxytocin signaling pathway	5/153	0.3349081751925745	1.0	0	0	1.3098091608052707	1.4327987853264361	CACNA2D3;CACNA2D4;CAMK1;PRKACA;CAMKK2
Intestinal immune network for IgA production	2/48	0.33747216444826783	1.0	0	0	1.67000668002672	1.814081910119734	IL2;HLA-DPA1
Arginine and proline metabolism	2/49	0.3465972728961172	1.0	0	0	1.6359249110465828	1.7334125719038218	ALDH4A1;P4HA2
Cocaine addiction	2/49	0.3465972728961172	1.0	0	0	1.6359249110465828	1.7334125719038218	PRKACA;CREB5
AMPK signaling pathway	4/120	0.3513719994759129	1.0	0	0	1.3360053440213762	1.397341067695801	AKT2;FBP1;CREB5;CAMKK2
Wnt signaling pathway	5/158	0.35963140842490604	1.0	0	0	1.2683595038177622	1.2971203641798388	FOSL1;FZD2;CSNK2A2;PRKACA;NKD1
Salmonella infection	3/86	0.3632482347064938	1.0	0	0	1.3981451274642307	1.4158579991575921	PYCARD;ARPC1B;WAS
Pantothenate and CoA biosynthesis	1/19	0.38139108902006696	1.0	0	0	2.1094821221390148	2.033392996431885	VNN2
Autoimmune thyroid disease	2/53	0.3826434235258837	1.0	0	0	1.5124588800241994	1.4529462434762603	IL2;HLA-DPA1
Epstein-Barr virus infection	6/201	0.3866749285151185	1.0	0	0	1.1964226961385458	1.1368060502242217	PDIA3;SYK;AKT2;BTK;HLA-DPA1;MAP2K6
Salivary secretion	3/90	0.3904133844435715	1.0	0	0	1.3360053440213762	1.2565786788347324	BST1;PRKACA;CST5
Pathogenic Escherichia coli infection	2/55	0.4003486021478105	1.0	0	0	1.4574603752960467	1.3341878025796103	ARPC1B;WAS
Regulation of lipolysis in adipocytes	2/55	0.4003486021478105	1.0	0	0	1.4574603752960467	1.3341878025796103	AKT2;PRKACA
Relaxin signaling pathway	4/130	0.4079847528236522	1.0	0	0	1.233235702173578	1.1056272246727736	AKT2;ARRB1;PRKACA;CREB5
Rap1 signaling pathway	6/206	0.4089412742798689	1.0	0	0	1.1673833103099402	1.043855147478949	ITGAM;AKT2;MAGI3;ITGB2;RASGRP2;MAP2K6
Glutathione metabolism	2/56	0.40911169681555504	1.0	0	0	1.43143429716576	1.2793688274765	GGT7;GCLM
Dopaminergic synapse	4/131	0.4136053986350768	1.0	0	0	1.2238216891798865	1.0804422929282882	GSK3A;AKT2;PRKACA;CREB5
Pyrimidine metabolism	2/57	0.41781177566433786	1.0	0	0	1.4063214147593432	1.2273307953808836	CDA;TK2
Influenza A	5/171	0.4239178993455579	1.0	0	0	1.1719345122994527	1.0057723354528425	PYCARD;AKT2;MAP2K6;HLA-DPA1;SLC25A6
NF-kappa B signaling pathway	3/95	0.4239403945022609	1.0	0	0	1.2656892732834089	1.0861669604089468	SYK;CSNK2A2;BTK
Human immunodeficiency virus 1 infection	6/212	0.4355599478721355	1.0	0	0	1.1343441600181496	0.9427793388865101	BST2;PDIA3;WEE2;AKT2;APOBEC3A;MAP2K6
Aldosterone synthesis and secretion	3/98	0.44375323966298486	1.0	0	0	1.2269436832849372	0.9968753477201518	CAMK1;PRKACA;CREB5
Choline metabolism in cancer	3/99	0.4502986517606096	1.0	0	0	1.2145503127467057	0.9690219782238011	CHKB;AKT2;WAS
Progesterone-mediated oocyte maturation	3/99	0.4502986517606096	1.0	0	0	1.2145503127467057	0.9690219782238011	AKT2;RPS6KA1;PRKACA
Measles	4/138	0.45257259296708846	1.0	0	0	1.1617437774098922	0.9210387177398254	AKT2;CSNK2A2;FCGR2B;IL2
Inflammatory mediator regulation of TRP channels	3/100	0.45681252344287365	1.0	0	0	1.2024048096192383	0.9420627720518913	TRPV2;PRKACA;MAP2K6
NOD-like receptor signaling pathway	5/178	0.458101133894999	1.0	0	0	1.1258472000180135	0.8789098453982915	PYCARD;CARD9;TRPV2;CARD16;TP53BP1
Ribosome biogenesis in eukaryotes	3/101	0.4632936620901169	1.0	0	0	1.1904998115041965	0.9159636102852832	GNL3L;CSNK2A2;REXO2
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	1/25	0.4684968242387519	1.0	0	0	1.6032064128256514	1.2155927148684615	PGAP1
alpha-Linolenic acid metabolism	1/25	0.4684968242387519	1.0	0	0	1.6032064128256514	1.2155927148684615	FADS2
Arachidonic acid metabolism	2/63	0.4685698743106791	1.0	0	0	1.27238604192512	0.9645577423859204	ALOX5;TBXAS1
Cytosolic DNA-sensing pathway	2/63	0.4685698743106791	1.0	0	0	1.27238604192512	0.9645577423859204	PYCARD;ZBP1
Maturity onset diabetes of the young	1/26	0.48177439669322825	1.0	0	0	1.5415446277169724	1.1257581796782758	HHEX
Central carbon metabolism in cancer	2/65	0.4848972014536226	1.0	0	0	1.233235702173578	0.8926386511807349	FLT3;AKT2
Cortisol synthesis and secretion	2/65	0.4848972014536226	1.0	0	0	1.233235702173578	0.8926386511807349	PRKACA;CREB5
Inflammatory bowel disease (IBD)	2/65	0.4848972014536226	1.0	0	0	1.233235702173578	0.8926386511807349	IL2;HLA-DPA1
Shigellosis	2/65	0.4848972014536226	1.0	0	0	1.233235702173578	0.8926386511807349	ARPC1B;WAS
Cell adhesion molecules (CAMs)	4/145	0.4906640074020756	1.0	0	0	1.1056595950521733	0.7872248641536519	SPN;ITGAM;ITGB2;HLA-DPA1
Human cytomegalovirus infection	6/225	0.4923545817365023	1.0	0	0	1.068804275217101	0.7573078182809101	PDIA3;AKT2;CXCR2;PRKACA;MAP2K6;CREB5
Non-small cell lung cancer	2/66	0.4929433227493972	1.0	0	0	1.2145503127467057	0.8591256155286086	RASSF1;AKT2
Parathyroid hormone synthesis, secretion and action	3/106	0.4951698034869171	1.0	0	0	1.1343441600181496	0.7972789403977747	ARRB1;PRKACA;CREB5
Long-term potentiation	2/67	0.500909536056892	1.0	0	0	1.1964226961385458	0.8271226165215465	RPS6KA1;PRKACA
Calcium signaling pathway	5/188	0.505856142597193	1.0	0	0	1.0659617106553532	0.7264560538993745	HRH2;P2RX1;CAMK1;PRKACA;SLC25A6
Phospholipase D signaling pathway	4/148	0.5066542646029109	1.0	0	0	1.0832475762335483	0.7365286593369689	CYTH4;SYK;AKT2;CXCR2
Drug metabolism	3/108	0.5076544218358136	1.0	0	0	1.11333778668448	0.7547921786577281	CDA;TK2;FMO5
Amphetamine addiction	2/68	0.5087948142513435	1.0	0	0	1.1788282447247436	0.7965465744715722	PRKACA;CREB5
Glycolysis / Gluconeogenesis	2/68	0.5087948142513435	1.0	0	0	1.1788282447247436	0.7965465744715722	LDHC;FBP1
Adipocytokine signaling pathway	2/69	0.516598230750829	1.0	0	0	1.1617437774098922	0.7673199420538523	AKT2;CAMKK2
TNF signaling pathway	3/110	0.519976372135044	1.0	0	0	1.093095281472035	0.714853605364382	AKT2;MAP2K6;CREB5
Ras signaling pathway	6/232	0.522163251448912	1.0	0	0	1.0365558703614124	0.673528088335841	RASSF1;FLT3;AKT2;PRKACA;RASGRP2;RASGRP4
Cholinergic synapse	3/112	0.5321293706426967	1.0	0	0	1.07357572287432	0.677285257626295	AKT2;PRKACA;CREB5
Adherens junction	2/72	0.5395094657929208	1.0	0	0	1.11333778668448	0.6870351246335921	CSNK2A2;WAS
Asthma	1/31	0.5433583388350804	1.0	0	0	1.2929083974400413	0.7886563481965001	HLA-DPA1
Bacterial invasion of epithelial cells	2/74	0.5543614743664991	1.0	0	0	1.0832475762335483	0.6390492598190445	ARPC1B;WAS
Metabolism of xenobiotics by cytochrome P450	2/74	0.5543614743664991	1.0	0	0	1.0832475762335483	0.6390492598190445	DHDH;CYP1A1
PPAR signaling pathway	2/74	0.5543614743664991	1.0	0	0	1.0832475762335483	0.6390492598190445	FADS2;FABP5
Propanoate metabolism	1/32	0.5547692049322223	1.0	0	0	1.25250501002004	0.7379798330323151	LDHC
Gastric acid secretion	2/75	0.5616593734581257	1.0	0	0	1.068804275217101	0.6165501241299798	HRH2;PRKACA
Glioma	2/75	0.5616593734581257	1.0	0	0	1.068804275217101	0.6165501241299798	AKT2;CAMK1
Base excision repair	1/33	0.5658954848618294	1.0	0	0	1.2145503127467057	0.6914992087824988	OGG1
Fructose and mannose metabolism	1/33	0.5658954848618294	1.0	0	0	1.2145503127467057	0.6914992087824988	FBP1
Cellular senescence	4/160	0.5681900837011026	1.0	0	0	1.0020040080160322	0.5664321260941193	CHEK2;AKT2;MAP2K6;SLC25A6
Herpes simplex virus 1 infection	12/492	0.5730705651077739	1.0	0	0	0.9775648858692996	0.5442557501094121	BST2;PDIA3;SYK;AKT2;CARD9;ZNF736;ZNF813;ZNF316;POU2F2;HLA-DPA1;ZNF233;ZNF563
Neurotrophin signaling pathway	3/119	0.5732577598581827	1.0	0	0	1.0104242097640659	0.5622200576600401	SORT1;AKT2;RPS6KA1
Antigen processing and presentation	2/77	0.5759972803565592	1.0	0	0	1.041043125211462	0.5742938759603243	PDIA3;HLA-DPA1
Pentose and glucuronate interconversions	1/34	0.5767442622659661	1.0	0	0	1.1788282447247436	0.6487755869007844	DHDH
Necroptosis	4/162	0.5780279881775666	1.0	0	0	0.9896335881639823	0.5424508167243636	PYCARD;ZBP1;PYGL;SLC25A6
Synaptic vesicle cycle	2/78	0.5830368232459177	1.0	0	0	1.0276964184779815	0.5544472873639099	TCIRG1;ATP6V0A1
Alanine, aspartate and glutamate metabolism	1/35	0.5873224448299629	1.0	0	0	1.145147437732608	0.6094260523423816	ALDH4A1
Prion diseases	1/35	0.5873224448299629	1.0	0	0	1.145147437732608	0.6094260523423816	PRKACA
Protein processing in endoplasmic reticulum	4/165	0.5925429513404824	1.0	0	0	0.9716402501973644	0.508490354659723	PDIA3;GANAB;HSPA4L;RNF185
Starch and sucrose metabolism	1/36	0.5976367686206209	1.0	0	0	1.11333778668448	0.5731152526311586	PYGL
Cell cycle	3/124	0.6012216714040295	1.0	0	0	0.969681298080031	0.4933656747431333	CDKN2D;WEE2;CHEK2
Cytokine-cytokine receptor interaction	7/294	0.602733518316735	1.0	0	0	0.95428953144384	0.48313780555348085	IL32;CX3CR1;IL11;TNFSF12;CXCR2;TNFRSF10C;IL2
Primary immunodeficiency	1/37	0.607693802400194	1.0	0	0	1.0832475762335483	0.5395484356233516	BTK
Chemical carcinogenesis	2/82	0.6103297683136937	1.0	0	0	0.9775648858692996	0.4826783949317437	SULT1A1;CYP1A1
Pyruvate metabolism	1/39	0.627061462527919	1.0	0	0	1.0276964184779815	0.4796369321136311	LDHC
Insulin secretion	2/86	0.6362406061926168	1.0	0	0	0.9320967516428205	0.42147408823246774	PRKACA;CREB5
Oxidative phosphorylation	3/133	0.6484353420182888	1.0	0	0	0.9040637666310063	0.39163408088389035	TCIRG1;COX6C;ATP6V0A1
Tryptophan metabolism	1/42	0.6543383244988259	1.0	0	0	0.95428953144384	0.4047435304314916	CYP1A1
Morphine addiction	2/91	0.6667063671398114	1.0	0	0	0.8808826444096985	0.35711472102140146	ARRB1;PRKACA
Estrogen signaling pathway	3/137	0.6681030399219701	1.0	0	0	0.8776677442476194	0.35397469329387315	AKT2;PRKACA;CREB5
Carbohydrate digestion and absorption	1/44	0.6714074145685438	1.0	0	0	0.9109127345600292	0.3628886418772273	AKT2
Th1 and Th2 cell differentiation	2/92	0.6725466986911268	1.0	0	0	0.8713078330574192	0.3456336407459404	IL2;HLA-DPA1
GnRH signaling pathway	2/93	0.6783038044085001	1.0	0	0	0.8619389316266943	0.3345702176875032	PRKACA;MAP2K6
IL-17 signaling pathway	2/93	0.6783038044085001	1.0	0	0	0.8619389316266943	0.3345702176875032	FOSL1;S100A8
Small cell lung cancer	2/93	0.6783038044085001	1.0	0	0	0.8619389316266943	0.3345702176875032	AKT2;ITGA2
Basal transcription factors	1/45	0.6796238418937326	1.0	0	0	0.8906702293475841	0.3439909218923916	TAF13
Glycosphingolipid biosynthesis	1/45	0.6796238418937326	1.0	0	0	0.8906702293475841	0.3439909218923916	FUT7
Transcriptional misregulation in cancer	4/186	0.6854402449482832	1.0	0	0	0.8619389316266943	0.32554912302340744	HHEX;SPI1;ITGAM;FLT3
Thermogenesis	5/231	0.6867233543557449	1.0	0	0	0.8675359376762182	0.3260406131631921	RPS6KA1;ZNF516;PRKACA;COX6C;CREB5
Parkinson disease	3/142	0.6915420213519045	1.0	0	0	0.8467639504360834	0.312313100555085	PRKACA;COX6C;SLC25A6
Apoptosis	3/143	0.6960774966956201	1.0	0	0	0.8408425242092578	0.30463243607704654	DFFB;AKT2;CTSF
Glycerophospholipid metabolism	2/97	0.700510519657976	1.0	0	0	0.8263950581575522	0.29415192939420687	CHKB;GPD1
Prostate cancer	2/97	0.700510519657976	1.0	0	0	0.8263950581575522	0.29415192939420687	AKT2;CREB5
Endocrine and other factor-regulated calcium reabsorption	1/48	0.70306312169229	1.0	0	0	0.83500334001336	0.29417885952429185	PRKACA
Pancreatic secretion	2/98	0.7058596239486489	1.0	0	0	0.8179624555232914	0.28492813724813587	BST1;RAB3D
Phosphatidylinositol signaling system	2/99	0.7111289165173832	1.0	0	0	0.8097002084978038	0.27602805484220155	IMPA2;INPPL1
N-Glycan biosynthesis	1/50	0.7177304776127647	1.0	0	0	0.8016032064128257	0.26586064911887247	GANAB
Human papillomavirus infection	7/330	0.7196779751239544	1.0	0	0	0.8501852189226939	0.2796696382527787	FZD2;AKT2;ITGA2;TCIRG1;PRKACA;ATP6V0A1;CREB5
Melanogenesis	2/101	0.7214306590779099	1.0	0	0	0.7936665410027977	0.2591472148263827	FZD2;PRKACA
T cell receptor signaling pathway	2/101	0.7214306590779099	1.0	0	0	0.7936665410027977	0.2591472148263827	AKT2;IL2
Non-alcoholic fatty liver disease (NAFLD)	3/149	0.7222332497744723	1.0	0	0	0.8069830937041869	0.262598053798359	GSK3A;AKT2;COX6C
Amyotrophic lateral sclerosis (ALS)	1/51	0.7247907172134752	1.0	0	0	0.7858854964831624	0.2529547972116268	MAP2K6
Chagas disease (American trypanosomiasis)	2/103	0.7314211003301349	1.0	0	0	0.7782555402066268	0.24341181348985963	AKT2;IL2
mTOR signaling pathway	3/152	0.7346388847219986	1.0	0	0	0.7910557958021305	0.24394279121925308	FZD2;AKT2;RPS6KA1
Focal adhesion	4/199	0.734953988080718	1.0	0	0	0.8056313632289706	0.24809206995262023	PARVG;AKT2;ITGA2;MYL12A
Toll-like receptor signaling pathway	2/104	0.7363013230243781	1.0	0	0	0.7707723138584862	0.23594561257439783	AKT2;MAP2K6
Ribosome	3/153	0.7386758224275315	1.0	0	0	0.7858854964831624	0.23804167148160577	RPS28;RPL36A;RPS10
Proteoglycans in cancer	4/201	0.7420256361526166	1.0	0	0	0.7976151307590305	0.23798561209239147	FZD2;AKT2;ITGA2;PRKACA
Viral carcinogenesis	4/201	0.7420256361526166	1.0	0	0	0.7976151307590305	0.23798561209239147	GSN;SYK;PRKACA;CREB5
Cushing syndrome	3/155	0.746603678064511	1.0	0	0	0.7757450384640249	0.22668882494900022	FZD2;PRKACA;CREB5
Th17 cell differentiation	2/107	0.7504906640453064	1.0	0	0	0.7491618751521735	0.21503048536885905	IL2;HLA-DPA1
Endometrial cancer	1/58	0.7695158178272834	1.0	0	0	0.6910372469076083	0.18104745348185977	AKT2
JAK-STAT signaling pathway	3/162	0.7728456291504839	1.0	0	0	0.7422251911229867	0.1912535841275644	IL11;AKT2;IL2
VEGF signaling pathway	1/59	0.7752830853042475	1.0	0	0	0.6793247511973098	0.17290652149302896	AKT2
Hepatitis B	3/163	0.7764071250883569	1.0	0	0	0.7376716623430911	0.18668865385614475	AKT2;MAP2K6;CREB5
Serotonergic synapse	2/113	0.7769061038386742	1.0	0	0	0.7093833685069253	0.17907374422987063	ALOX5;PRKACA
Steroid hormone biosynthesis	1/60	0.7809063226585379	1.0	0	0	0.6680026720106881	0.16519711537479384	CYP1A1
cGMP-PKG signaling pathway	3/166	0.786817427110367	1.0	0	0	0.7243402467585773	0.17366712463016767	AKT2;CREB5;SLC25A6
Thyroid hormone signaling pathway	2/116	0.7891741420869729	1.0	0	0	0.6910372469076083	0.16361569351488306	AKT2;PRKACA
Basal cell carcinoma	1/63	0.7969473087674392	1.0	0	0	0.63619302096256	0.14439463965261765	FZD2
Mitophagy	1/65	0.8069846249700656	1.0	0	0	0.616617851086789	0.13223410696801885	CSNK2A2
Retinol metabolism	1/67	0.8165267159212919	1.0	0	0	0.5982113480692729	0.12125483627334348	CYP1A1
Oocyte meiosis	2/125	0.8224780675106375	1.0	0	0	0.6412825651302605	0.12532807204085417	RPS6KA1;PRKACA
Renal cell carcinoma	1/69	0.8255979685294595	1.0	0	0	0.5808718887049461	0.11132255517230018	AKT2
Renin secretion	1/69	0.8255979685294595	1.0	0	0	0.5808718887049461	0.11132255517230018	PRKACA
Prolactin signaling pathway	1/70	0.8299643219162436	1.0	0	0	0.572573718866304	0.1067120324984155	AKT2
Alcoholism	3/180	0.8302078926551616	1.0	0	0	0.6680026720106881	0.12430136037149637	PRKACA;CREB5;CAMKK2
Axon guidance	3/181	0.832996475961432	1.0	0	0	0.6643120495133914	0.121386995446854	ABLIM2;PLXNA1;MYL12A
Bile secretion	1/72	0.8383724366978841	1.0	0	0	0.55666889334224	0.09813674127799288	PRKACA
Melanoma	1/72	0.8383724366978841	1.0	0	0	0.55666889334224	0.09813674127799288	AKT2
p53 signaling pathway	1/72	0.8383724366978841	1.0	0	0	0.55666889334224	0.09813674127799288	CHEK2
FoxO signaling pathway	2/132	0.8450357037586851	1.0	0	0	0.6072751563733528	0.10225080436554118	CDKN2D;AKT2
Kaposi sarcoma-associated herpesvirus infection	3/186	0.8463559860545536	1.0	0	0	0.6464541987200206	0.10783839975663262	SYK;AKT2;MAP2K6
Systemic lupus erythematosus	2/133	0.848037229565078	1.0	0	0	0.6027091777540042	0.09934500059663758	FCGR3B;HLA-DPA1
Pancreatic cancer	1/75	0.8502129361466166	1.0	0	0	0.5344021376085505	0.08671660534791123	AKT2
Neuroactive ligand-receptor interaction	6/338	0.8508766599134817	1.0	0	0	0.7114821358693719	0.11489589573329576	P2RY13;NMB;HRH2;P2RX1;NMUR1;TRH
Chronic myeloid leukemia	1/76	0.8539641476060756	1.0	0	0	0.5273705305347537	0.08325391192950704	AKT2
Pathways in cancer	10/530	0.8551767871234071	1.0	0	0	0.7562294400120997	0.11830987473336262	RASSF1;SPI1;FZD2;FLT3;AKT2;ITGA2;PRKACA;RASGRP2;RASGRP4;IL2
Apelin signaling pathway	2/137	0.8595217868648974	1.0	0	0	0.5851118294984129	0.08857370576439137	AKT2;PRKACA
Huntington disease	3/193	0.8634967225271649	1.0	0	0	0.6230076733778438	0.09143583143724944	COX6C;CREB5;SLC25A6
RNA degradation	1/79	0.8646645091586458	1.0	0	0	0.5073438015271048	0.07377473832091228	DDX6
Fluid shear stress and atherosclerosis	2/139	0.864961723669963	1.0	0	0	0.5766929542538314	0.08366086020781142	AKT2;MAP2K6
Signaling pathways regulating pluripotency of stem cells	2/139	0.864961723669963	1.0	0	0	0.5766929542538314	0.08366086020781142	FZD2;AKT2
ECM-receptor interaction	1/82	0.874582276140101	1.0	0	0	0.4887824429346498	0.06550120011368539	ITGA2
Peroxisome	1/83	0.8777242858210957	1.0	0	0	0.4828934978390516	0.06298030273751755	PECR
Taste transduction	1/83	0.8777242858210957	1.0	0	0	0.4828934978390516	0.06298030273751755	PRKACA
PI3K-Akt signaling pathway	6/354	0.8790900258876756	1.0	0	0	0.6793247511973098	0.08754320030678356	SYK;FLT3;AKT2;ITGA2;IL2;CREB5
ErbB signaling pathway	1/85	0.8837745785440082	1.0	0	0	0.47153129788989745	0.0582592245714919	AKT2
Breast cancer	2/147	0.8848428940528873	1.0	0	0	0.5453083036821943	0.06671583743110317	FZD2;AKT2
Colorectal cancer	1/86	0.8866867338848907	1.0	0	0	0.46604837582141023	0.05604862465843398	AKT2
Gastric cancer	2/149	0.8893718848234373	1.0	0	0	0.5379887291361246	0.06307369789365115	FZD2;AKT2
Gap junction	1/88	0.8922943838883216	1.0	0	0	0.4554563672800146	0.051903431439404756	PRKACA
GABAergic synapse	1/89	0.8949934685943387	1.0	0	0	0.4503388800072054	0.04996008123837179	PRKACA
Protein digestion and absorption	1/90	0.8976250454053264	1.0	0	0	0.44533511467379205	0.04809745801282963	KCNJ13
TGF-beta signaling pathway	1/90	0.8976250454053264	1.0	0	0	0.44533511467379205	0.04809745801282963	FST
cAMP signaling pathway	3/212	0.9018226443701314	1.0	0	0	0.5671720800090748	0.058610089870042056	AKT2;PRKACA;CREB5
Circadian entrainment	1/97	0.9142922549685927	1.0	0	0	0.4131975290787761	0.03702456659437544	PRKACA
AGE-RAGE signaling pathway in diabetic complications	1/100	0.9205786360531582	1.0	0	0	0.40080160320641284	0.033167476719405835	AKT2
HIF-1 signaling pathway	1/100	0.9205786360531582	1.0	0	0	0.40080160320641284	0.033167476719405835	AKT2
Hepatocellular carcinoma	2/168	0.9248542806691006	1.0	0	0	0.47714476572192	0.037274114081183224	FZD2;AKT2
Alzheimer disease	2/171	0.9293660991886609	1.0	0	0	0.46877380491978105	0.034338871433979595	LRP1;COX6C
Glutamatergic synapse	1/114	0.9443473858006073	1.0	0	0	0.3515803536898358	0.020131908412181005	PRKACA
Sphingolipid signaling pathway	1/119	0.9509884907676591	1.0	0	0	0.3368080699213553	0.016925723296067292	AKT2
Vascular smooth muscle contraction	1/132	0.9647834675707313	1.0	0	0	0.3036375781866764	0.010885889584778046	PRKACA
Spliceosome	1/134	0.9665301641296526	1.0	0	0	0.29910567403463645	0.010182386016131795	PCBP1
Retrograde endocannabinoid signaling	1/148	0.976560834442874	1.0	0	0	0.27081189405838707	0.006423179372059655	PRKACA
Hepatitis C	1/155	0.9803868568269408	1.0	0	0	0.25858167948800825	0.005121994530302603	AKT2
Olfactory transduction	3/444	0.9990524090875965	1.0	0	0	0.27081189405838707	2.567405515075597E-4	SLC24A4;ARRB1;PRKACA
MicroRNAs in cancer	1/299	0.9995027045420388	1.0	0	0	0.13404735893191064	6.667772338749869E-5	RASSF1
